Reminder: Corporate Access: H Lundbeck CEO *Tues 16th Jun* Barclays Conversations with the C-Suite in European Healthcare 2026

Research evidence excerpt

Reminder: Corporate Access: H Lundbeck CEO *Tues 16th Jun* Barclays Conversations with the C-Suite in European Healthcare 2026

without written consent from Barclays Research. Barclays' Investment Bankers are prohibited from

attending this event. Participant comments are not for attribution.

If your firm is in-scope for research unbundling under MiFID II and you require further information

regarding pricing to participate in this Barclays Research content event, please contact your sales

representative.

Barclays Events Terms of Service | Barclays Events Privacy Notice

Disclaimer:

BARCLAYS

This communication has been prepared by Barclays.

“Barclays” means any entity within the Barclays Group of companies, where “Barclays Group” means

Barclays Bank PLC, Barclays PLC and any of their subsidiaries, affiliates, ultimate holding company

and any subsidiaries or affiliates of such holding company.

CONFLICTS OF INTEREST

BARCLAYS IS A FULL SERVICE INVESTMENT BANK. In the normal course of offering investment banking

products and services to clients, Barclays may act in several capacities (including issuer, market

maker and/or liquidity provider, underwriter, distributor, index sponsor, swap counterparty and

calculation agent) simultaneously with respect to a product, giving rise to potential conflicts of

interest which may impact the performance of a product.

BARCLAYS POSITIONS

Barclays may at any time acquire, hold or dispose of long or short positions (including hedging and

trading positions) and trade or otherwise effect transactions for their own account or the account of

their customers in the products referred to herein which may impact the performance of a product.

FOR INFORMATION ONLY

THIS DOCUMENT IS PROVIDED FOR INFORMATION PURPOSES ONLY AND IT IS SUBJECT TO CHANGE.